Stifel Downgrades Insulet to Hold, Lowers Price Target to $165

Benzinga · 2d ago
Stifel analyst Jonathan Block downgrades Insulet (NASDAQ:PODD) from Buy to Hold and lowers the price target from $180 to $165.